News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McNulty Alana B.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2023 |
4
| McNulty Alana B. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/22/2022 |
4
| McNulty Alana B. (Chief Business Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.49, valued at
$223.5k
|
|
| 06/16/2022 |
4
| McNulty Alana B. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $10.73, valued at
$134.1k
|
|
| 01/24/2022 |
4
| McNulty Alana B. (Chief Business Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $6.65, valued at
$997.5k
|
|
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|